Anavex Life Sciences Corp.
USD2.60
-0.02 (-0.76%)
CEO
Christopher U. Missling
IPO Date
2006-08-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.60
Prev. Close
$2.62
Day Low
$2.50
Day High
$2.61
52W Low
$2.41
52W High
$13.99
Market Cap
$0.24B
Volume
0.78M
| -11.0 |
| 30 Sept 2023 | FY | 0.0% | 0.0% | -33.5% | -30.8% | 0.00 | 12.32 | -11.0 |
| 30 Sept 2022 | FY | 0.0% | 0.0% | -33.7% | -31.4% | 0.00 | 14.95 | -16.5 |
| 30 Sept 2021 | FY | 0.0% | 0.0% | -25.1% | -23.5% | 0.00 | 14.97 | -33.1 |
| 30 Sept 2020 | FY | 0.0% | 0.0% | -96.5% | -76.1% | 0.00 | 4.73 | -10.1 |
| 30 Sept 2019 | FY | 0.0% | 0.0% | -129.6% | -103.8% | 0.00 | 5.03 | -5.9 |
| 30 Sept 2018 | FY | 0.0% | 0.0% | -85.2% | -71.6% | 0.00 | 6.26 | -6.6 |
| 30 Sept 2017 | FY | 0.0% | 0.0% | -55.5% | -48.4% | 0.00 | 7.75 | -12.6 |
| 30 Sept 2016 | FY | 0.0% | 0.0% | -233.6% | -155.1% | 0.00 | 2.96 | -8.7 |
| -19.4 |
| 30 Jun 2025 | Q3 | 0.0% | 0.0% | -14.6% | -12.9% | 0.00 | 8.82 | -14.9 |
| 31 Mar 2025 | Q2 | 0.0% | 0.0% | -11.2% | -9.6% | 0.00 | 6.74 | -16.3 |
| 31 Dec 2024 | Q1 | 0.0% | 0.0% | -10.9% | -9.8% | 0.00 | 9.45 | -18.8 |
| 30 Sept 2024 | Q4 | 0.0% | 0.0% | -9.7% | -8.6% | 0.00 | 8.86 | -10.3 |
| 30 Jun 2024 | Q3 | 0.0% | 0.0% | -9.4% | -8.6% | 0.00 | 12.04 | -7.1 |
| 31 Mar 2024 | Q2 | 0.0% | 0.0% | -7.8% | -7.3% | 0.00 | 15.12 | -9.8 |
| 31 Dec 2023 | Q1 | 0.0% | 0.0% | -6.4% | -5.8% | 0.00 | 11.85 | -22.2 |
| 30 Sept 2023 | Q4 | 0.0% | 0.0% | -7.2% | -6.6% | 0.00 | 12.32 | -12.9 |